Three-dimensional bioprinting human cardiac tissue chips of using a painting needle method.


Journal

Biotechnology and bioengineering
ISSN: 1097-0290
Titre abrégé: Biotechnol Bioeng
Pays: United States
ID NLM: 7502021

Informations de publication

Date de publication:
11 2019
Historique:
received: 04 02 2019
revised: 26 05 2019
accepted: 17 07 2019
pubmed: 2 8 2019
medline: 17 9 2020
entrez: 2 8 2019
Statut: ppublish

Résumé

Three-dimensional (3D) printers are attracting attention as a method for arranging and building cells in three dimensions. Bioprinting technology has potential in tissue engineering for the fabrication of scaffolds, cells, and tissues. However, these various printing technologies have limitations with respect to print resolution and due to the characteristics of bioink such as viscosity. We report a method for constructing of 3D tissues with a "microscopic painting device using a painting needle method" that, when used with the layer-by-layer (LbL) cell coating technique, replaces conventional methods. This method is a technique of attaching the high viscosity bioink to the painting needle tip and arranging it on a substrate, and can construct 3D tissues without damage to cells. Cell viability is the same before and after painting. We used this biofabrication device to construct 3D cardiac tissue (LbL-3D Heart) using human-induced pluripotent stem cell-derived cardiomyocytes. The constructed LbL-3D Heart chips had multiple layers with a thickness of 60 µm, a diameter of 1.1 mm, and showed synchronous beating (50-60 beats per min). The aforementioned device and method of 3D tissue construction can be applied to various kinds of tissue models and would be a useful tool for pharmaceutical applications.

Identifiants

pubmed: 31369146
doi: 10.1002/bit.27126
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3136-3142

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Auteurs

Shohei Chikae (S)

NTN Corporation, Iwata, Japan.
Building Block Science Joint Research Chair, Graduate School of Frontier Biosciences, Osaka University, Suita, Japan.

Akifumi Kubota (A)

Building Block Science Joint Research Chair, Graduate School of Frontier Biosciences, Osaka University, Suita, Japan.

Haruka Nakamura (H)

NTN Corporation, Iwata, Japan.

Atsushi Oda (A)

NTN Corporation, Iwata, Japan.
Building Block Science Joint Research Chair, Graduate School of Frontier Biosciences, Osaka University, Suita, Japan.

Akihiro Yamanaka (A)

NTN Corporation, Iwata, Japan.

Takami Akagi (T)

Building Block Science Joint Research Chair, Graduate School of Frontier Biosciences, Osaka University, Suita, Japan.

Mitsuru Akashi (M)

Building Block Science Joint Research Chair, Graduate School of Frontier Biosciences, Osaka University, Suita, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH